Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
32.7%
% of PINK's 53 holdings also in GDOC
37.8%
% of GDOC's 48 holdings also in PINK
Overlap by Weight
Sector Drift (PINK minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PINK |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
BOSTON SCIENTIFIC CORP | 5.8% | 5.5% | 5.5% |
|
ELI LILLY & CO | 5.1% | 8.4% | 5.1% |
|
INTUITIVE SURGICAL INC | 3.9% | 4.9% | 3.9% |
|
DEXCOM INC | 2.9% | 2.9% | 2.9% |
|
ZIMMER HOLDINGS INC | 3.3% | 2.8% | 2.8% |
Position Highlights (Non-Overlapping Exposures)
PINK Overweight Relative to GDOC
 |
SANOFI-AVENTIS-ADR | 7.8% |
|
REGENERON PHARMACEUTICALS | 6.3% |
|
CIGNA CORPORATION | 4.9% |
|
JOHNSON & JOHNSON | 4.7% |
|
VERTEX PHARMACEUTICALS INC | 4.6% |
|
AMGEN INC | 4.3% |
 |
MEDTRONIC PLC | 4.3% |
|
UNITEDHEALTH GROUP INC | 4.1% |
|
ABBVIE INC | 3.6% |
|
MERCK & CO. INC. | 3.6% |
PINK Underweight Relative to GDOC
 |
ASTRAZENECA PLC | -5.2% |
|
ELI LILLY & CO | -3.3% |
|
BIOGEN IDEC INC | -3.3% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% |
|
SEATTLE GENETICS INC | -3.1% |
 |
CSL LIMITED | -2.9% |
|
BIOMARIN PHARMACEUTICAL INC | -2.8% |
|
BRISTOL-MYERS SQUIBB CO | -2.8% |
|
NEUROCRINE BIOSCIENCES INC | -2.8% |
|
WEST PHARMACEUTICAL SERVICES | -2.5% |